Connection
Brent Palmer to CCR5 Receptor Antagonists
This is a "connection" page, showing publications Brent Palmer has written about CCR5 Receptor Antagonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.089 |
|
|
|
-
Matalon S, Palmer BE, Nold MF, Furlan A, Kassu A, Fossati G, Mascagni P, Dinarello CA. The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4(+) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro. J Acquir Immune Defic Syndr. 2010 May 01; 54(1):1-9.
Score: 0.089